Ezetimibe Effectively Reduces Plasma Plant Sterols in Patients With Sitosterolemia

Autor: B. Musser, John P. Kane, K. von Bergmann, D. Lütjohann, P. Stein, Shailendra B. Patel, T. Musliner, P. Kwiterovich, G. Salen
Rok vydání: 2004
Předmět:
Zdroj: Circulation. 109:966-971
ISSN: 1524-4539
0009-7322
DOI: 10.1161/01.cir.0000116766.31036.03
Popis: Background— Sitosterolemia is a recessively inherited disorder that results from mutations in either ABCG5 or G8 proteins, with hyperabsorption of dietary sterols and decreased hepatic excretion of plant sterols and cholesterol. As a consequence of markedly elevated plasma and tissue sitosterol and campesterol levels, premature atherosclerosis develops. Methods and Results— In this multicenter, double-blind, randomized, placebo-controlled study, we examined whether treatment with ezetimibe, an inhibitor of cholesterol absorption, reduces plant sterol levels in patients with sitosterolemia. After a 3-week placebo run-in, 37 patients were randomized to receive placebo (n=7) or ezetimibe 10 mg/d (n=30) for 8 weeks. Sitosterol concentrations decreased by 21% ( P P P Conclusions— Ezetimibe produced significant and progressive reductions in plasma plant sterol concentrations in patients with sitosterolemia, consistent with the hypothesis that ezetimibe inhibits the intestinal absorption of plant sterols as well as cholesterol, leading to reductions in plasma concentrations.
Databáze: OpenAIRE